From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. Pediatrics and Adolescent Medicine>
  4. News in Context

The Sting of the HPV Vaccine

More reports of fainting and pain with Gardasil than with other routine vaccines

The first human papillomavirus (HPV) vaccine, Gardasil, was licensed for use in 2006 and is approved by the FDA for use in girls and women aged 9 to 26 years. According to the Associated Press, this vaccine is gaining a reputation as being more painful than other routine immunizations. Merck & Co. acknowledge that premarketing studies indicated more reports of pain with Gardasil shots as compared with placebo shots. The company attributes the pain to viruslike particles in Gardasil. Reports to the CDC about vaccine-associated fainting also have increased since Gardasil entered the market, from 50 reports between 2002 and 2004 to 230 reports between 2005 and July 2007 (180 following Gardasil administration).

Comment: More pain and fainting may be associated with Gardasil. The increase in fainting may be secondary to the vaccine itself or simply related to the increase in the number of injections now being given to adolescents. A second HPV vaccine is under review by the FDA, but we will need to wait for postmarketing data to determine whether it too is associated with similar side effects. Having teens recline while they receive Gardasil injections and for a few minutes afterward seems prudent. For those with complaints of troublesome pain after the first injection, a dose of ibuprofen might alleviate the discomfort for the remaining injections in the series. We should continue to follow AAP recommendations for use of HPV vaccines as part of the teen platform.

Peggy Sue Weintrub, MD

Published in Journal Watch Pediatrics and Adolescent Medicine January 16, 2008

Citation(s):

Stobbe M. Ouch! Cervical cancer shots painful. Associated Press. Jan 4 , 2008. (http://tinyurl.com/2r5mde)

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. Please consider this when composing your remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Article Tools

Reader Remarks

Sign-In

Forgot your password?

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Journal Watch Newsletters

Available in 13 specialties with convenient delivery and 10 free online CME exams.

Subscribe Now!

Copyright © 2008. Massachusetts Medical Society. All rights reserved.